Form: DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

May 14, 2014

 

EXHIBIT 21.1

 

 

Subsidiaries of the Registrant

 

EyeGate Pharma S.A.S.   (France)